5,156 Shares in CVS Health Co. (NYSE:CVS) Purchased by Everpar Advisors LLC

Everpar Advisors LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 5,156 shares of the pharmacy operator’s stock, valued at approximately $305,000.

Other large investors have also recently made changes to their positions in the company. USA Financial Formulas raised its holdings in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the 4th quarter valued at about $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $34,000. Steph & Co. raised its holdings in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of CVS Health in the 4th quarter valued at about $36,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Truist Financial restated a “buy” rating and issued a $66.00 price target (down previously from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. SVB Leerink reiterated a “market perform” rating and set a $60.00 price objective (down previously from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Bank of America reduced their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Finally, Argus reduced their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Eleven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $73.24.

CVS Health Stock Performance

Shares of CVS stock traded up $0.79 during trading hours on Friday, hitting $58.35. The company’s stock had a trading volume of 7,442,666 shares, compared to its average volume of 11,432,018. The company has a 50 day moving average of $59.04 and a 200 day moving average of $65.61. The stock has a market cap of $73.25 billion, a PE ratio of 10.25, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 EPS. On average, sell-side analysts forecast that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.56%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.